Fulgent Genetics Forecast, price target & analysts
Fulgent Genetics Target price 2026 - Analyst rating & recommendation
Fulgent Genetics Classifications & Recommendation
Fulgent Genetics Price Target
| Target Price | $19.38 |
| Price | $21.48 |
| Deviation |
9.78%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Fulgent Genetics 2027 .
The average Fulgent Genetics target price is $19.38.
This is
9.78%
register free of charge
$19.95
7.12%
register free of charge
$19.19
10.66%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Fulgent Genetics to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Fulgent Genetics stock has an average upside potential 2027 of
9.78%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 322.67 | 338.33 |
| 13.83% | 4.85% | |
| EBITDA Margin | -25.74% | -22.61% |
| 10.66% | 12.18% | |
| Net Margin | -18.75% | -18.83% |
| 24.46% | 0.41% |
3 Analysts have issued a sales forecast Fulgent Genetics 2026 . The average Fulgent Genetics sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Fulgent Genetics EBITDA forecast 2026. The average Fulgent Genetics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Fulgent Genetics Analysts have issued a net profit forecast 2026. The average Fulgent Genetics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.97 | -2.32 |
| 39.72% | 17.77% | |
| P/E | negative | |
| EV/Sales | 1.00 |
3 Analysts have issued a Fulgent Genetics forecast for earnings per share. The average Fulgent Genetics EPS is
This results in the following potential growth metrics and future valuations:
Fulgent Genetics...
Current Fulgent Genetics Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 05 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 05 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 04 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | May 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 05 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 05 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 04 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
May 05 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
